• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION INFINION CX; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION INFINION CX; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF Back to Search Results
Model Number SC-2317-70
Device Problems High impedance (1291); Unexpected Therapeutic Results (1631)
Patient Problem Inadequate Pain Relief (2388)
Event Date 06/09/2022
Event Type  Injury  
Manufacturer Narrative
Exact date unknown: event occurred two weeks ago from date manufacturer was made aware.Additional suspect medical device component involved in the event: product family: scs-linear leads.Upn: m365sc2317700.Model: sc-2317-70.Serial: 7076319.Batch: 7076319.
 
Event Description
It was reported that the patient experienced inadequate and loss of stimulation despite reprogramming attempt.It was noted that the patients lead had high impedances.The patient underwent a revision procedure where in the leads were removed and a new paddle was implanted.
 
Manufacturer Narrative
Sc-2317-70 (sn: (b)(6).The returned leads were analyzed and visual (microscope) and x-ray inspection of the leads revealed that multiple cables were completely broken at the bent/kinked location of the leads.The bent/kinked location was 2 cm from the set screw mark of the clik x anchor.There were no exposed cables at the fractured location.The leads got kinked after it exited the clik x anchor resulting in the reported complaint.With all the available information, boston scientific concludes that the allegation of high impedance has been confirmed.It appeared that the leads were exposed to excessive mechanical force or movement causing the cable fractures right at the anchor point.
 
Event Description
It was reported that the patient experienced inadequate and loss of stimulation despite reprogramming attempt.It was noted that the patients lead had high impedances.The patient underwent a revision procedure wherein the leads were removed and a new paddle was implanted.Additional information was received that the patient was doing well postoperatively.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFINION CX
Type of Device
STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key15198512
MDR Text Key297687436
Report Number3006630150-2022-03947
Device Sequence Number1
Product Code LGW
UDI-Device Identifier08714729861638
UDI-Public08714729861638
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/14/2023
Device Model NumberSC-2317-70
Device Catalogue NumberSC-2317-70
Device Lot Number7076279
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/19/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age39 YR
Patient SexFemale
-
-